Alivus Life Sciences Limited (NSE:ALIVUS)

Alivus Life Sciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	255.81	19.82	710.62	3,014	2,838	5,122
Short-Term Investments	9,862	7,804	4,776	-	-	1.11
Cash & Short-Term Investments	10,117	7,824	5,487	3,014	2,838	5,123
Cash Growth	54.98%	42.59%	82.03%	6.20%	-44.59%	332.66%
Accounts Receivable	9,882	10,730	9,697	7,654	8,068	6,735
Other Receivables	14.5	322.92	398.65	903.68	709.4	57.94
Receivables	9,896	11,053	10,096	8,558	8,777	6,793
Inventory	7,828	6,919	6,739	6,666	6,042	5,162
Prepaid Expenses	-	63.09	22.56	8.06	1.38	1.63
Other Current Assets	807.14	635.02	1,007	913.88	845.01	566.28
Total Current Assets	28,648	26,494	23,352	19,160	18,503	17,646
Property, Plant & Equipment	14,181	12,914	10,369	8,962	8,242	6,763
Long-Term Investments	0.77	0.77	0.77	0.77	0.77	0.77
Other Intangible Assets	362.1	299.26	199.37	148.53	180.01	103.8
Other Long-Term Assets	226.66	121.57	193.59	232.86	94.86	196.3
Total Assets	43,419	39,829	34,115	28,504	27,021	24,710

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	4,273	3,724	3,905	3,687	4,272	3,077
Accrued Expenses	197.96	703.42	479.38	385.91	361.1	447.76
Current Portion of Leases	84.3	79.77	56.48	23.87	22.65	16.8
Current Income Taxes Payable	290.28	64.58	-	-	70.78	120.03
Current Unearned Revenue	-	48.73	29.67	52.58	19.43	-
Other Current Liabilities	791.3	460.18	231.42	238.76	219.21	178.19
Total Current Liabilities	5,637	5,080	4,702	4,388	4,965	3,840
Long-Term Leases	444.7	487.94	509.58	147.61	170.92	12.04
Pension & Post-Retirement Benefits	377.63	361.48	185.35	157.71	78.7	-
Long-Term Deferred Tax Liabilities	647.14	577.88	544.29	487.85	424.34	314.95
Total Liabilities	7,107	6,508	5,941	5,181	5,639	4,167

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	245.54	245.47	245.07	245.05	245.05	245.05
Additional Paid-In Capital	-	10,188	10,057	10,050	10,050	10,050
Retained Earnings	-	22,815	17,772	12,918	11,021	10,214
Comprehensive Income & Other	36,067	72.46	99.69	110.58	66.83	34.98
Shareholders' Equity	36,313	33,321	28,174	23,323	21,382	20,543
Total Liabilities & Equity	43,419	39,829	34,115	28,504	27,021	24,710

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	529	567.71	566.06	171.48	193.57	28.84
Net Cash (Debt)	9,588	7,256	4,921	2,843	2,645	5,094
Net Cash Growth	61.87%	47.46%	73.10%	7.49%	-48.08%	-
Net Cash Per Share	77.93	59.00	40.04	23.17	21.58	43.34
Filing Date Shares Outstanding	122.77	122.74	122.54	122.53	122.53	122.53
Total Common Shares Outstanding	122.77	122.74	122.54	122.53	122.53	122.53
Working Capital	23,011	21,413	18,650	14,772	13,538	13,806
Book Value Per Share	295.78	271.49	229.92	190.35	174.51	167.66
Tangible Book Value	35,951	33,022	27,974	23,175	21,202	20,439
Tangible Book Value Per Share	292.83	269.05	228.29	189.14	173.04	166.81
Buildings	-	3,830	3,678	3,164	3,017	2,235
Machinery	-	7,903	7,225	6,273	5,743	4,426
Construction In Progress	-	2,734	942.52	1,012	493.54	916.88

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error